Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma From Covalescent Donors With Covid-19 for the Management of Patients With SARS-COV-2 Fase II and III, a Doble Center Randomized Doble Blind Trial

NCT04405310 is registered in ClinicalTrials.gov with Grupo Mexicano para el Estudio de la Medicina Intensiva as lead sponsor.

NCT NCT04405310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04405310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma From Covalescent Donors With Covid-19 for the Management of Patients With SARS-COV-2 Fase II and III, a Doble Center Randomized Doble Blind Trial
Lead sponsor
Grupo Mexicano para el Estudio de la Medicina Intensiva
Phase
Phase 2
Overall status
Completed
Start date
May 20, 2020
Completion date
December 10, 2020
Enrollment
42 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sars pneumonia